Gene expression networks in endothelial cells from failing human hearts

Luisa Wirth1, Elias Erny1, Markus Krane2,3,4

  • 1Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Insights

Researchers identified key gene networks and transcription factors, including CASZ1, ZNF523, and NFE2L1, that regulate angiogenesis in heart failure. This finding offers new insights beyond traditional signaling pathways.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Genomics

Background:

  • Chronic heart failure involves adverse cardiac remodeling and cardiomyocyte hypertrophy.
  • Adequate oxygen supply necessitates new capillary formation (angiogenesis).
  • Impaired angiogenesis exacerbates heart failure progression.

Purpose of the Study:

  • To identify angiogenesis-related gene networks in endothelial cells from failing human hearts.
  • To pinpoint regulatory hub genes controlling angiogenesis in heart failure.
  • To explore transcriptional regulation of angiogenesis beyond established pathways.

Main Methods:

  • Isolation of left ventricular endothelial cells from heart failure patients and healthy donors.
  • RNA sequencing and weighted gene coexpression network analysis.
  • Validation of identified hub genes (CASZ1, ZNF523, NFE2L1) via knockdown experiments.

Main Results:

  • Identified 26 gene clusters, with 9 significantly correlated with heart failure.
  • Discovered CASZ1, ZNF523, and NFE2L1 as hub genes in an angiogenesis-related cluster.
  • Knockdown of these transcription factors downregulated key angiogenesis genes (e.g., CD34).

Conclusions:

  • CASZ1, ZNF523, and NFE2L1 are potential regulators of angiogenesis in failing human hearts.
  • These findings expand understanding of transcriptional control of angiogenesis in heart failure.
  • The study highlights novel targets for therapeutic intervention in heart failure.